3
Announcements
Trials
Browse
Landscape
Status
Unknown
5
Terminated
1
No longer available
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Cirrhosis
1
Hepatitis D
1
Hepatitis B
1
Fibrosis
1
Esophageal and Gastric Varices
1
Carcinoma, Hepatocellular
1
Interventions
regorafenib
3
zanidatamab
1
peginterferon alfa-2a
1
pegilodecakin
1
onvansertib
1
omburtamab I-131
1
guselkumab
1
derazantinib
1
avapritinib
1
Tenofovir
1
Melphalan
1
Imatinib Mesylate
1
IMM-101
1
IFL protocol
1
HMPL-013
1
Everolimus
1
Brachytherapy
1
Bevacizumab
1
AM0010
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
peginterferon alfa-2a
×
Gastrointestinal
×
Clear all
NCT05683548
2025-02-17
RCAP
Replicor Inc.
No longer available